ACR Congress Do Not Miss… ACR Convergence 2023: Do Not Miss – Spondyloarthritis I – Non-therapeutic 6 Nov 2023 Clementina López-MedinaClementina López-Medina is a rheumatologist and postdoctoral researcher at the Spondyloarthritis Unit of the Reina Sofia University Hospital in Cordoba, Spain. Her work focuses on the epidemiology and real-world…
ACR Congress Do Not Miss… ACR Convergence 2023: Do Not Miss – Spondyloarthritis II – Therapeutic 6 Nov 2023 Diego BenaventDiego is a consultant rheumatologist at Hospital de Bellvitge, Barcelona. Aside from his activities regarding healthcare technology, his major interests are spondyloarthritis, patient-reported outcomes and musculoskeletal epidemiology. Diego the…
Spondyloarthritis [EULAR HL 2023] Spondyloarthritis I – Clinical (Non-therapeutic) 20 Jun 2023 Author: Gizem Ayan Marques et al. (OP005) searched the sustainability of a baseline diagnosis of axSpA when reviewed after 2 years and showed that most of the patients can be…
Spondyloarthritis… Spondyloarthritis I – Non-therapeutic 29 May 202330 May 2023 Tania Gudu Tania is a Rheumatology Consultant at Ipswich Hospital, UK where she leads the Spondyloarthritis service. Her main research interests are spondyloarthritis/ psoriatic arthritis, patient reported outcomes and MSK…
Spondyloarthritis [ACR22] Spondyloarthritis I – Non-therapeutic 29 Nov 20226 Dec 2022 Author: Jean-Guillaume Letarouilly Sieiro Santos et al. (0373) developed a prognostic outcome score for patients with uveitis associated with SpA (SpA-U) and determine factors associated with adverse outcomes in uveitis…